December 14, 2022 / Clin Auton Res Comment to the article: "Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension" by Jordan and colleagues L. Moreno Velásquez T. Pischon
September 01, 2020 / Haematologica Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia F.E.M. In't Hout M. Gerritsen L. Bullinger B.A. Van der Reijden G. Huls E. Vellenga J.H. Jansen
September 01, 2020 / Haematologica The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia S. Grasedieck C. Ruess K. Krowiorz S. Lux N. Pochert A. Schwarzer J.H. Klusmann M. Jongen-Lavrencic T. Herold L. Bullinger J.R. Pollack A. Rouhi F. Kuchenbauer
February 01, 2020 / Leukemia Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML) M. Agrawal P. Schwarz B.D. Giaimo I. Bedzhov A. Corbacioglu D. Weber V.I. Gaidzik N. Jahn F.G. Rücker T. Schroeder T. Kindler M. Wattad K. Götze M. Lübbert H. Salwender M. Ringhoffer E. Lange E. Koller F. Thol M. Heuser A. Ganser L. Bullinger P. Paschka H. Döhner H. Geiger T. Borggrefe K. Döhner F. Oswald
September 01, 2022 / Med Res Arch Why angiotensin II is a poor choice for circulatory support of ventilated COVID-19 patients compared to vasopressin R.C. Speth M. Bader
January 01, 2020 / Nat Methods CLIJ: GPU-accelerated image processing for everyone R. Haase L.A. Royer P. Steinbach D. Schmidt A. Dibrov U. Schmidt M. Weigert N. Maghelli P. Tomancak F. Jug E.W. Myers
October 11, 2022 / J Hum Genet A novel MAP3K20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a Pakistani family I. Ahmad A. Khan H. Noor Ul Ayan B. Budde J. Altmüller A.A. Korejo G. Nürnberg H. Thiele M. Tariq P. Nürnberg J. Erdmann
January 01, 2023 / Haematologica Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B cell impairment and increases the risk for infections - a retrospective matched cohort study. M. Launspach D. Temel E. Ohlendorf F. Zirngibl B. Materne L. Oevermann H.E. Deubzer A.G. Henssen A. Künkele P. Hundsdörfer H. von Bernuth A. Pruß A. Eggert A. von Stackelberg P. Lang J.H. Schulte
October 01, 2022 / Kidney Int Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer S. Gupta I.A. Strohbehn Q. Wang P.E. Hanna R. Seethapathy J.M. Prosek S.M. Herrmann A. Abudayyeh A.B. Malik S. Loew C.A. Carlos W.T. Chang P. Beckerman Z. Mithani C.V. Shah A. Renaghan S. de Seigneux L. Campedel A. Kitchlu D.S. Shin G. Coppock N. Lumlertgul P. Garcia D.I. Ortiz-Melo A. Rashidi B. Sprangers V. Aggarwal K. Benesova K.D. Jhaveri F.B. Cortazar A. Weins Y. Zuo M.J. Mooradian K.L. Reynolds D.E. Leaf M.E. Sise
September 01, 2022 / HemaSphere Genotype and intensive pretreatment influence outcome of acute myeloid leukemia patients treated with venetoclax in combination with hypomethylating agents or low-dose cytarabine: "real world" data from germany K. Braitsch L.K. Schmalbrock P. Jung I. Bumeder P. Kiewe J.S. Hecker M. Verbeek J. Westermann L. Bullinger U. Keller F. Bassermann J. Krönke K.S. Götze K. Rieger
